News

Strategies to Remove Pre-Existing AAV Antibodies: IgG Enzymatic Degradation vs FcRn Inhibition. Presented by Yash Shah, PhD, ...
The University at Albany hosted its third annual Showcase Day, recognizing the creative and innovative work of students ...
Forge Biologics ("Forge"), a leading manufacturer of genetic medicines and member of the Ajinomoto Bio-Pharma Services group, ...
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting Sonoma Biotherapeutics, Inc., a clinical-stage ...
Weill Cornell Medicine Qatar (WCM Q) recently hosted its second annual Student Research Forum, showcasing 66 impressive ...
Seven Northwestern undergraduate students took home awards for their research at the Chicago Area Undergraduate Research ...
Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that the ...
The popular symposium, which celebrates undergraduate research across all disciplines, transformed the Hassenfeld Conference ...
FORE Biotherapeutics has announced that its plixorafenib abstract has been selected for poster presentation at the highly ...
Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid ...
Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened ...
Georgia Southwestern University Georgia Southwestern State University (GSW) hosted its 7th Annual Undergraduate Research ...